Nearing 100 Orders, ABI Says SOLiD System Claims 40 Percent of Second-Gen Purchases | GenomeWeb
Applied Biosystems last week reported 10-percent growth of its DNA sequencing business for the fourth quarter of its fiscal year 2008, which ended June 30.
 
Since its May launch of the SOLiD 2.0, the platform’s first upgrade, demand for the sequencer has picked up and ABI officials said they believe it now represents about 40 percent of all new orders for second-generation sequencing systems.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.